![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Starting Treatment -Induction, Consolidation, Maintenance
1. When should a patient consider starting treatment? Video
2. Should frailty and functional status be assessed before treatment is started? how is it assessed? Video
3. What is induction therapy? Video
4. What drugs are available in the induction setting? Is there an optimal induction therapy? Video
5. Are there special factors you consider when selecting induction therapy for individuals diagnosed with high risk multiple myeloma (HRMM)? Video
6. How can induction therapy be modified for frail or transplant ineligible patients? Video
7. When are tandem or allogeneic transplants considered? Video
8. What factors should you consider when choosing a treatment regimen? Video
9. Who should consider ASCT as part of induction? Why consider ASCT if in a complete remission? Video
10. Can ASCT be delayed? Should I get transplant upfront or delay? Video
11. What is risk stratification? What is risk adaptive therapy? Video
12. What is consolidation therapy? Video
13. What is maintenance therapy and how does it differ from consolidation and induction? Video
14. What are some therapies being used in the maintenance setting? Can maintenance therapy be adapted to risk status? Video
15. What are the typical dosages of maintenance therapy? Can they be adjusted? Video
16. I'm in a complete response, why should I consider maintenance therapy? Should I consider maintenance therapy if I am MRD negative? Video
17. Is maintenance therapy continuous or a fixed duration? Why? What is response adaptive therapy? How can MRD status be used guide maintenance therapy? Video
18. Is response the same as remission? Video
19. What are myeloma markers? How are they useful? Video
20. How will a patient know if they are responding to treatment? Video
21. Should all myeloma patients take bone strengthening therapy? Video
22. What are some recommended prophylactic medications? Video
23. What vaccinations should myeloma patients be getting to help prevent infections? Video
24. What treatment is used for a solitary plasmacytoma? Video
25. What is extramedullary disease and how is it treated? Video
26. When and why should I bring up side effects to treatment? Video
27. Can patients be given treatment free intervals? Video
28. Is it safe to be intimate with your partner who is on chemo and radiation? Video
29. What types of dental work and safely be done during induction therapy Video
30. What are the different catheters and ports? When are each used? Video
31. BETA - Can myeloma therapy be received through a dialysis port? Video
32. Are there any foods, drinks, or supplements that individuals on myeloma therapy should avoid? Video
33. Are there any tests that can predict what myeloma treatments you will respond to? Video
34. When should a patient consider changing a therapy? Video
35. What should younger individuals diagnosed with myeloma know about preserving fertility before starting treatment? Video
35. BETA - What should younger individuals diagnosed with myeloma know about preserving fertility before starting treatment? Video
36. When should a NDMM consider a clinical trial as a treatment option? Video
37. Why is it important to have a BMB before myeloma treatment is started? Video
38. What should individuals who are starting treatment know about blood clots? Video
40. (Guest Lecture): An Increasing Arsenal of Therapeutic Options | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma Video
41. (Guest Lecture): Balancing Today with Tomorrow’s Opportunity | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma Video
42. (Guest Lecture): A Discussion of Two Case Studies | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma Video
43. (Guest Lecture): Myeloma Diagnosis and Staging | MCRT Webcast: Experts Discuss Newly Diagnosed Multiple Myeloma Issues Video
44. (Guest Lecture): Myeloma Treatment | MCRT Webcast: Experts Discuss Newly Diagnosed Multiple Myeloma Issues Video
45. (Guest Lecture): Stem Cell Transplant | MCRT Webcast: Experts Discuss Newly Diagnosed Multiple Myeloma Issues Video
46. (Guest Lecture): May 2022 - Translating Ideas Into Treatment - Dickran Kazandjian, MD Video
47. (Guest Lecture): June 2022 - How to Tell Your Family, Friends, and Loved Ones You Have Cancer - Presentation Video
48. (Guest Lecture): June 2022 - Measuring Serum BCMA for Non-Secretory Myeloma Patients with Dr. James Berenson Video
49. (Guest Lecture): September 2022 - Evolution of Myeloma Therapy Video
50. (Guest Lecture): September 2022 - Diagnosis: A Never-Ending Story Video
51. (Guest Lecture): November 2022 - How Myeloma Frontline Therapy is Changing - Ajai Chari, MD Video
52. (Guest Lecture) Syed Abbas Ali Presents Case Studies: Discussion with Morning Faculty | RT Austin, TX Mar 25, 2023 - Video
53. (Guest Lecture) Putting Your Disease Into Your Context - William Matsui, MD | RT Austin, TX Mar 25, 2023 Video
54. (Guest Lecture) So Many Choices: Deciding Which Treatment is Best - Matthew Butler, MD | RT Austin, TX Mar 25, 2023 Video
55. (Guest Lecture) What's Available for Consolidation Therapy? Video
56. (Guest Lecture) What's Available for Induction Therapy in Multiple Myeloma? Video
57. (Guest Lecture): September 2023 - Setting Up Your Expectations For Having Myeloma Video
58. (Guest Lecture): September 2023 - Essential Treatment Strategies for Newly Diagnosed Myeloma Patients Video
59. (Guest Lecture): October 2023 - Extending Remissions for Newly Diagnosed Myeloma Patients Video
60. (Guest Lecture): March 2024 - Advancement of Life-Changing Care for the Newly Diagnosed Myeloma Patient Video
61. (Guest Lecture): The Ever-Changing Landscape of Treatment | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma Video
What types of dental work and safely be done during induction therapy
2 years ago
Lesson Description
Learn about how to approach dental work while one treatment.